SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
22.81
-0.84 (-3.57%)
At close: Apr 28, 2026, 4:00 PM EDT
23.00
+0.20 (0.86%)
After-hours: Apr 28, 2026, 4:10 PM EDT
SpyGlass Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -39.87 | -29.16 |
| Depreciation & Amortization | 0.61 | 0.27 |
| Loss (Gain) From Sale of Assets | 0.01 | - |
| Stock-Based Compensation | 2.79 | 1.49 |
| Other Operating Activities | 1.32 | 4.04 |
| Change in Accounts Receivable | -0.01 | -0.3 |
| Change in Accounts Payable | 0.55 | 1.34 |
| Change in Other Net Operating Assets | 1.91 | 0.3 |
| Operating Cash Flow | -32.7 | -22.03 |
| Capital Expenditures | -0.79 | -1.99 |
| Investment in Securities | -11.01 | 24.25 |
| Investing Cash Flow | -11.79 | 22.26 |
| Issuance of Common Stock | 0.17 | 0.19 |
| Repurchase of Common Stock | -1.45 | - |
| Other Financing Activities | -1.47 | - |
| Financing Cash Flow | 124.59 | 0.19 |
| Net Cash Flow | 80.09 | 0.42 |
| Free Cash Flow | -33.49 | -24.02 |
| Free Cash Flow Per Share | -15.11 | -13.43 |
| Cash Income Tax Paid | 0 | 0.02 |
| Levered Free Cash Flow | -22.24 | - |
| Unlevered Free Cash Flow | -22.24 | - |
| Change in Working Capital | 2.45 | 1.34 |
Source: S&P Capital IQ. Standard template.
Financial Sources.